Professor Tamura, please introduce yourself.
My name is Yuichi Tamura from Japan, I’m the director of the Pulmonary Hypertension centre in downtown Tokyo.
What needs to be done in the future to improve the treatment of Pulmonary Hypertension?
I think It is really important to find changes in deep phenotypes in each patient because in the near future we must focus on different treatment responses for each patient.
How did you become interested in Pulmonary Hypertension treatment?
Pulmonary Hypertension is a rare disease and during my residency there were not many treatment strategies, so I decided to engage in this field because there is a need to develop novel treatments for patients.
My role is to perform research from Japan and the Western Asian countries because there is a scarcity of data from these areas. I created a national Japanese registry to improve research and to produce real-world evidence from this region.
How do you think the WSPHA will help in improving the knowledge and treatment of Pulmonary Hypertension?
We are very excited about this new Association because the World Symposium is held every five years so there’s not much continuity between these events. Now we can work together more easily, we can discuss, we can have an ongoing exchange among the experts.